Pseudo-Thrombotic Microangiopathy Secondary to Vitamin B12 Deficiency.

IF 0.8 Q3 MEDICINE, GENERAL & INTERNAL
Case Reports in Medicine Pub Date : 2022-09-03 eCollection Date: 2022-01-01 DOI:10.1155/2022/7306070
Dylan Morrissey, Yuheng Sun, Sarina Koilpillai, Jacqueline Kropf, Steve J Carlan
{"title":"Pseudo-Thrombotic Microangiopathy Secondary to Vitamin B12 Deficiency.","authors":"Dylan Morrissey,&nbsp;Yuheng Sun,&nbsp;Sarina Koilpillai,&nbsp;Jacqueline Kropf,&nbsp;Steve J Carlan","doi":"10.1155/2022/7306070","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Clinical B<sub>12</sub> deficiency with hematological or neurological manifestations is rare. An unusual manifestation of B<sub>12</sub> deficiency is pseudo-thrombotic microangiopathy (TMA), which is characterized by hemolytic anemia, thrombocytopenia, and schistocytosis and only occurs in 2.5% of those with B<sub>12</sub> deficiency. Pseudo-TMA is misdiagnosed as thrombotic thrombocytopenic purpura (TTP) in 40% of cases, resulting in misguided treatment including plasmapheresis.</p><p><strong>Case: </strong>A 44-year-old Hispanic presented with 3 weeks of progressively worsening non-radiating chest pain, fatigue, and shortness of breath (SOB). Laboratory findings revealed severe pancytopenia and macrocytosis with a hemoglobin of 5.4 g/dL, mean corpuscular volume of 116.3 fL, and vitamin B<sub>12</sub> low at 149 pg/mL. She was diagnosed with pseudo-TMA and after starting 1000 micrograms of parenteral vitamin B<sub>12</sub> injections daily and discontinuing plasmapheresis and steroid administration, she improved.</p><p><strong>Conclusion: </strong>Failure to recognize pseudo-TMA often results in unnecessary treatment with plasmapheresis and delays appropriate treatment with vitamin B<sub>12</sub> supplementation. It is therefore extremely important to consider pseudo-TMA as a differential diagnosis in patients that present with hemolytic anemia, thrombocytopenia, and schistocytosis.</p>","PeriodicalId":9627,"journal":{"name":"Case Reports in Medicine","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2022-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464104/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/7306070","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 2

Abstract

Background: Clinical B12 deficiency with hematological or neurological manifestations is rare. An unusual manifestation of B12 deficiency is pseudo-thrombotic microangiopathy (TMA), which is characterized by hemolytic anemia, thrombocytopenia, and schistocytosis and only occurs in 2.5% of those with B12 deficiency. Pseudo-TMA is misdiagnosed as thrombotic thrombocytopenic purpura (TTP) in 40% of cases, resulting in misguided treatment including plasmapheresis.

Case: A 44-year-old Hispanic presented with 3 weeks of progressively worsening non-radiating chest pain, fatigue, and shortness of breath (SOB). Laboratory findings revealed severe pancytopenia and macrocytosis with a hemoglobin of 5.4 g/dL, mean corpuscular volume of 116.3 fL, and vitamin B12 low at 149 pg/mL. She was diagnosed with pseudo-TMA and after starting 1000 micrograms of parenteral vitamin B12 injections daily and discontinuing plasmapheresis and steroid administration, she improved.

Conclusion: Failure to recognize pseudo-TMA often results in unnecessary treatment with plasmapheresis and delays appropriate treatment with vitamin B12 supplementation. It is therefore extremely important to consider pseudo-TMA as a differential diagnosis in patients that present with hemolytic anemia, thrombocytopenia, and schistocytosis.

继发于维生素B12缺乏的假性血栓性微血管病。
背景:临床B12缺乏伴血液学或神经学表现是罕见的。B12缺乏的一种不寻常的表现是假性血栓性微血管病(TMA),其特征是溶血性贫血、血小板减少症和血吸虫病,仅发生在2.5%的B12缺乏症患者中。假性tma在40%的病例中被误诊为血栓性血小板减少性紫癜(TTP),导致包括血浆置换在内的错误治疗。病例:一名44岁的西班牙裔患者,表现为3周逐渐加重的非辐射性胸痛、疲劳和呼吸短促(SOB)。实验室结果显示严重的全血细胞减少和巨细胞增多,血红蛋白为5.4 g/dL,平均红细胞体积为116.3 fL,维生素B12低至149 pg/mL。她被诊断为假性tma,在开始每天注射1000微克的肠外维生素B12并停止血浆置换和类固醇治疗后,她好转了。结论:假性tma的识别失败往往导致不必要的血浆置换治疗,并延误适当的维生素B12补充治疗。因此,考虑假性tma作为溶血性贫血、血小板减少症和血吸虫病患者的鉴别诊断是极其重要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Case Reports in Medicine
Case Reports in Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
1.70
自引率
0.00%
发文量
53
审稿时长
13 weeks
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信